Integrated Filing — IndAS


General information about company

Scrip Code 523694
NSE Symbol APCOTEXIND
MSEI Symbol NOTLISTED
ISIN INE116A01032
Name of company APCOTEX INDUSTRIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 07-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 30-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacture of Synthetic Emulsion Polymers
Start date and time of board meeting 07-May-2025   11:30:00
End date and time of board meeting 07-May-2025   14:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. No
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-01-28
Indicate Company website link for updated RPT policy of the Company https://apcotex.com/investor-corporate-policy
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 3493962000 13923560000
Other income 9291000 103825000
Total income 3503253000 14027385000
2 Expenses
(a) Cost of materials consumed 2412515000 10220996000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 22500000 80398000
(d) Employee benefit expense 208180000 745048000
(e) Finance costs 43840000 173238000
(f) Depreciation, depletion and amortisation expense 105287000 415771000
(f) Other Expenses
1 Other Expenses 466179000 1629476000
Total other expenses 466179000 1629476000
Total expenses 3258501000 13264927000
3 Total profit before exceptional items and tax 244752000 762458000
4 Exceptional items 0 0
5 Total profit before tax 244752000 762458000
6 Tax expense
7 Current tax 79215000 211359000
8 Deferred tax -2013000 10453000
9 Total tax expenses 77202000 221812000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 167550000 540646000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 167550000 540646000
17 Other comprehensive income net of taxes -32143000 58968000
18 Total Comprehensive Income for the period 135407000 599614000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 103690000 103690000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.23 10.43
Diluted earnings (loss) per share from continuing operations 3.23 10.43
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.23 10.43
Diluted earnings (loss) per share from continuing and discontinued operations 3.23 10.43
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 3842193000
Capital work-in-progress 119427000
Investment property 14468000
Goodwill 0
Other intangible assets 3820000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 833980000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 56000
Total non-current financial assets 834036000
Deferred tax assets (net) 0
Other non-current assets 90831000
Total non-current assets 4904775000
2 Current assets
Inventories 1377754000
Current financial asset
Current investments 225984000
Trade receivables, current 2540352000
Cash and cash equivalents 265419000
Bank balance other than cash and cash equivalents 124977000
Loans, current 5044000
Other current financial assets 177017000
Total current financial assets 3338793000
Current tax assets (net) 28137000
Other current assets 338726000
Total current assets 5083410000
3 Non-current assets classified as held for sale 344000
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 9988529000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 103690000
Other equity 5428147000
Total equity attributable to owners of parent 5531837000
Non controlling interest
Total equity 5531837000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 623582000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 82768000
Total non-current financial liabilities 706350000
Provisions, non-current 36508000
Deferred tax liabilities (net) 205722000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 948580000
Current liabilities
Current financial liabilities
Borrowings, current 1224309000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 147709000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1728735000
Total Trade payable 1876444000
Other current financial liabilities 244317000
Total current financial liabilities 3345070000
Other current liabilities 138707000
Provisions, current 24335000
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 3508112000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 4456692000
Total equity and liabilites 9988529000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Item that will not be reclassified to Statement of Profit and Loss -44923000 55201000
Total Amount of items that will not be reclassified to profit and loss -44923000 55201000
2 Income tax relating to items that will not be reclassified to profit or loss -12780000 -3767000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -32143000 58968000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 762458000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 173238000
Adjustments for decrease (increase) in inventories -127479000
Adjustments for decrease (increase) in trade receivables, current -577627000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets -2725000
Adjustments for other financial assets, non-current -1761000
Adjustments for other financial assets, current -2426000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 417692000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities -15941000
Adjustments for depreciation and amortisation expense 415771000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 12772000
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 291514000
Net cash flows from (used in) operations 1053972000
Dividends received -2468000
Interest paid 0
Interest received -6529000
Income taxes paid (refund) 192743000
Other inflows (outflows) of cash -5029000
Net cash flows from (used in) operating activities 847203000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 86287000
Purchase of property, plant and equipment 499520000
Proceeds from sales of investment property 413419000
Purchase of investment property 300086000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 2468000
Interest received 5920000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 4026000
Net cash flows from (used in) investing activities -287486000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 332263000
Repayments of borrowings 312500000
Payments of lease liabilities 10309000
Dividends paid 281500000
Interest paid 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash -172820000
Net cash flows from (used in) financing activities -444866000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 114851000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 114851000
Cash and cash equivalents cash flow statement at beginning of period 376552000
Cash and cash equivalents cash flow statement at end of period 491403000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Manubhai & Shah LLP Yes 29-Feb-2028


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Apcotex Industries Limited Abhiraj Choksey Vice-Chairman (w.e.f. 6th May, 2024) & Managing Director Remuneration Approved in AGM held on 29th July 2024 10719000 870000 0
2 Apcotex Industries Limited Ravishankar Sharma Executive Director Remuneration Approved in AGM datedn19th June 2023 4741000 534000 651000
3 Apcotex Industries Limited Sachin J Karwa Chief Financial Officer Remuneration Approved by Nomination & Remuneration Committee on 16th August 2022 and by the Board of Directors on 24th August 2022 3928000 515000 509000
4 Apcotex Industries Limited Jeevan Mondkar Company Secretary & Compliance Officer (upto 24th October 2024) Remuneration Approved on 20th October 2022 Meeting by Nomination & Remuneration Committee Meeting and Board Meeting 965000 255000 0
5 Apcotex Industries Limited Drigesh Mittal Company Secretary & Compliance Officer (w.e.f 25th October 2024) Remuneration Approved on 24th October 2024 Meeting by Nomination & Remuneration Committee Meeting and Board Meeting 1639000 0 281000
6 Apcotex Industries Limited Choksey Chemicals Pvt. Ltd Entities in which some of the Directors are interested Sale of goods or services 15000000 Approved in 27th Apriln2023 321000 7051000 331000
7 Apcotex Industries Limited Apco Enterprises LLP Entities in which some of the Directors are interested Any other transaction Professional Fees for Services rendered for Accounting and Investment Consultancy Passed in Meeting dated 6th May 2024 275000 0 0
8 Apcotex Industries Limited Atul C.Choksey Chairman and Non-Executive Director Any other transaction Reimbursement of medical Expenses Special Resolution passed at the Annual General Meeting held on 4-6-2019 439000 0 0
9 Apcotex Industries Limited Parul Atul Choksey Relative of Chairman and Non-Executive Director Any other transaction Leasing of premises and allied expenses 4000000 Approved in 27th April 2023 Meeting 812000 0 0
10 Apcotex Industries Limited Atul C.Choksey Chairman and Non-Executive Director Any other transaction Sitting Fees Approved in 6th Mayn2021 Meeting 120000 0 0
11 Apcotex Industries Limited Achala Vasudev Danait Independent Director Any other transaction Sitting Fees Approved on 2nd September 2023 150000 0 0
12 Apcotex Industries Limited Amit C Choksey Non Executive Director Any other transaction Sitting Fees Approved in 6th May 2021 60000 0 0
13 Apcotex Industries Limited Dinanath Narcinva Prabhu-Kholkar Independent Director Any other transaction Sitting Fees Approved on 30th July 2024 210000 0 0
14 Apcotex Industries Limited Priti Paras Savla Independent Director Any other transaction Sitting Fees Approved on 7th March 2024 150000 0 0
15 Apcotex Industries Limited Udayan Dileep Choksi Independent Director Any other transaction Sitting Fees Approved on 30th July 2024 150000 0 0
Total value of transaction during the reporting period 24679000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt